Amgen Demands Injunction In Biosimilar Suit
Amgen Inc. asked a California federal judge on Friday to grant it a preliminary injunction in its fight with Sandoz Inc. over a biosimilar version of Neupogen, arguing that Sandoz's market...To view the full article, register now.
Already a subscriber? Click here to view full article